Tl. Bach et al., ENDOTHELIAL-CELL VE-CADHERIN FUNCTIONS AS A RECEPTOR FOR THE BETA-15-42 SEQUENCE OF FIBRIN, The Journal of biological chemistry, 273(46), 1998, pp. 30719-30728
The content of fibrin with the apical surface of human umbilical vein
endothelial cells (HUVEC) can induce capillary tube formation via the
interaction of fibrin beta 15-42 with a putative cell receptor (Chalup
owicz, D. G., Chowdhury, Z. A., Bach, T. L., Barsigian, C., and Martin
ez, J. (1945) J. Cell Biol. 130, 207-215). To characterize this intera
ction, we studied the binding of the thrombin-cleaved N-terminal disul
fide knot of fibrin (NDSK II), a dimeric fragment with exposed beta 15
-42, to HUVEC in three separate assay systems. Time-course binding of
I-125-NDSK II to HUVEC monolayers or suspensions revealed that binding
was specific at 50-60%, as determined by the addition of unlabeled ND
SK II. Specific binding of I-125-NDSK II to HUVEC was 70% reversible b
y dilution or by competition, and was found to be divalent cation-inde
pendent. Binding plateaued after 10 min at a saturation of 15-20 nM. S
catchard analysis using the LIGAND computer program defined a single p
opulation of receptors with a K-D of 7.7 +/- 1.6 nM and approximately
21,000 +/- 7000 binding sites/cell. N-terminal disulfide knot derivati
ves in which beta 15-42 was absent (NDSK 325) or unexposed (NDSK, NDSK
I) did not show specific binding. Specific binding of I-125-NDSK II c
ould not be inhibited by RGDS or by antibodies to the alpha(v)beta(3)
or beta(1) integrins, PECAM-1, ICAM-1, or N-cadherin, In contrast, a s
ynthetic beta 15-42/ovalbumin conjugate inhibited total I-125-NDSK II
binding by 47 +/- 19% (corresponding to 95% of specific I-125-NDSK II
bound) and a monoclonal antibody to vascular endothelial cadherin (VE-
cadherin) inhibited binding by 35 +/- 8% (corresponding to 70% of spec
ific 125I-NDSK II bound). Another assay was based on the capture of ca
dherins from HUVEC lysates by a polyclonal pan-cadherin antibody immob
ilized on plastic dishes. Binding of NDSK II to the captured cadherins
was 89 +/- 5% specific, while specific binding of NDSK 325 and NDSK w
as negligible. An immortalized line of human adipose-derived microvasc
ular endothelial cells, which express N-cadherin but not VE-cadherin,
demonstrated no specific binding of NDSK II by the capture assay. Thes
e data define a novel interaction of fibrin with VE-cadherin, which is
mediated by the fibrin N-terminal beta 15-42 sequence, and may contri
bute to the mechanism through which fibrin induces angiogenesis.